Rothschild & Co

Rothschild & Co expands wealth‑management services and upgrades Meta Platforms to “buy,” raising its target to $900 while adding neutral coverage on Chime Financial.

Rothschild & Co guides IndiaRF’s sale of Synthimed Labs stake, leveraging cross‑border expertise to secure buyers, navigate regulations, and maximize value.